HCV coinfection linked to higher rates of drug-induced liver injury in TB

Back to the "HIV and Co-Infections News" list

A systematic review and meta-analysis, published in BMC Infectious Diseases, revealed a higher prevalence of TB drug-induced liver injury in patients with vs without hepatitis C virus (HCV) co-infection highlighting the importance of routine HCV screening prior to TB treatment initiation.

Read the full news story here.

/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/


For more TB updates, check out the TB CAB Weekly Newsletter (Issue #38, 12 December 2025).

The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.


 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.